Largest pharmaceuticals by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceuticals ranked by total assets, at PLN 613.6M, followed by Erasca (PLN 1.6B) and Definium Therapeutics (PLN 1.8B). Figures as of 18 Nov 2026, 15:26 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsPLN 613.6M
- Median
- PLN 14.2B
- Combined market value
- PLN 20.52T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | PLN 613.6M | PLN 21.3B | PLN 504.00 | 0.22% down | 233% up | ||
| 2 | ErascaERAS · Health Care | PLN 1.6B | PLN 19.1B | PLN 54.32 | 2.74% down | 403% up | ||
| 3 | Definium TherapeuticsDFTX · Health Care | PLN 1.8B | PLN 16B | PLN 116.99 | 0.95% down | 169% up | ||
| 4 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 1.9B | PLN 32.9B | PLN 474.41 | 1.19% up | 13% up | ||
| 5 | Oruka TherapeuticsORKA · Health Care | PLN 2B | PLN 26.5B | PLN 391.27 | 1.04% up | 241% up | ||
| 6 | Dianthus TherapeuticsDNTH · Health Care | PLN 2.1B | PLN 19.9B | PLN 353.88 | 1.20% up | 113% up | ||
| 7 | Edgewise TherapeuticsEWTX · Health Care | PLN 2.2B | PLN 18.3B | PLN 167.03 | 1.18% down | 88% up | ||
| 8 | Travere TherapeuticsTVTX · Health Care | PLN 2.4B | PLN 19.4B | PLN 202.45 | 1.46% down | 44% up | ||
| 9 | ABIVAXABVX · Health Care | PLN 2.6B | PLN 29.5B | PLN 336.61 | 1.98% up | 27% down | ||
| 10 | Protagonist TherapeuticsPTGX · Health Care | PLN 2.7B | PLN 33B | PLN 505.91 | 0.93% up | 46% up | ||
| 11 | Axsome TherapeuticsAXSM · Health Care | PLN 2.8B | PLN 28.3B | PLN 538.94 | 1.40% down | 7% down | ||
| 12 | Summit TherapeuticsSMMT · Health Care | PLN 3B | PLN 35B | PLN 43.70 | 1.87% up | 36% down | ||
| 13 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 3.1B | PLN 30.5B | PLN 388.05 | 1.48% up | 126% up | ||
| 14 | Spyre TherapeuticsSYRE · Health Care | PLN 3.1B | PLN 36.9B | PLN 388.31 | 2.96% up | 286% up | ||
| 15 | Belite BioBLTE · Health Care | PLN 3.1B | PLN 25.9B | PLN 637.70 | 0.57% up | 31% up | ||
| 16 | Corcept TherapeuticsCORT · Health Care | PLN 3.4B | PLN 30.3B | PLN 276.69 | 1.78% down | 8% down | ||
| 17 | Mirum PharmaceuticalsMIRM · Health Care | PLN 3.4B | PLN 24B | PLN 367.51 | 0.59% down | 31% up | ||
| 18 | BridgeBio PharmaBBIO · Health Care | PLN 3.8B | PLN 61B | PLN 312.95 | 1.35% up | 17% up | ||
| 19 | Cogent BiosciencesCOGT · Health Care | PLN 3.8B | PLN 20.1B | PLN 115.49 | 3.14% up | 20% down | ||
| 20 | Praxis Precision MedicinesPRAX · Health Care | PLN 3.8B | PLN 34.6B | PLN 1,238.05 | 0.94% up | 61% up | ||
| 21 | TG TherapeuticsTGTX · Health Care | PLN 4.3B | PLN 39B | PLN 257.99 | 2.33% up | 107% up | ||
| 22 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 5.1B | PLN 39.1B | PLN 1,684.38 | 0.72% down | 24% down | ||
| 23 | Arrowhead PharmaceuticalsARWR · Health Care | PLN 5.6B | PLN 24.7B | PLN 174.69 | 1.07% up | 10% up | ||
| 24 | CytokineticsCYTK · Health Care | PLN 5.7B | PLN 29.2B | PLN 209.30 | 0.79% up | 20% down | ||
| 25 | Ascendis PharmaASND · Health Care | PLN 5.8B | PLN 71.7B | PLN 1,092.61 | 0.21% up | 28% up | ||
| 26 | Ligand PharmaceuticalsLGND · Health Care | PLN 6.3B | PLN 23.9B | PLN 1,192.80 | 0.98% up | 43% up | ||
| 27 | Legend BiotechLEGN · Health Care | PLN 7B | PLN 12.7B | PLN 65.69 | 1.43% up | 42% down | ||
| 28 | InsmedINSM · Health Care | PLN 9.1B | PLN 106.9B | PLN 487.23 | 0.55% down | 40% down | ||
| 29 | AlkermesALKS · Health Care | PLN 10B | PLN 31.2B | PLN 185.94 | 1.76% up | 58% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | PLN 11.7B | PLN 20.4B | PLN 243.96 | 0.53% up | 20% down | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | PLN 14.2B | PLN 18.1B | PLN 108.51 | 0.11% up | 64% down | ||
| 32 | Amneal PharmaceuticalsAMRX · Health Care | PLN 14.8B | PLN 30.3B | PLN 86.92 | 2.37% up | 83% up | ||
| 33 | Alnylam PharmaceuticalsALNY · Health Care | PLN 20B | PLN 83.1B | PLN 620.33 | 1.41% down | 66% down | ||
| 34 | Roivant SciencesROIV · Health Care | PLN 23B | PLN 114.1B | PLN 157.52 | 1.21% up | 90% up | ||
| 35 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 24.8B | PLN 50.2B | PLN 60.23 | 1.29% up | 5% up | ||
| 36 | BioMarin PharmaceuticalBMRN · Health Care | PLN 30.5B | PLN 46.8B | PLN 241.57 | 2.69% up | 11% up | ||
| 37 | United TherapeuticsUTHR · Health Care | PLN 31.7B | PLN 98.6B | PLN 2,314.64 | 1.43% down | 23% up | ||
| 38 | BeOne MedicinesONC · Health Care | PLN 32.9B | PLN 186.4B | PLN 1,631.73 | 1.79% down | 17% up | ||
| 39 | Jazz PharmaceuticalsJAZZ · Health Care | PLN 46.9B | PLN 63B | PLN 981.06 | 1.38% up | 37% up | ||
| 40 | GenmabGMAB · Health Care | PLN 51.8B | PLN 128B | PLN 207.65 | 0.60% down | 70% up | ||
| 41 | Elanco Animal HealthELAN · Health Care | PLN 53.7B | PLN 53.4B | PLN 106.74 | 2.71% up | 20% up | ||
| 42 | ZoetisZTS · Health Care | PLN 62.2B | PLN 137.7B | PLN 338.96 | 0.99% up | 29% down | ||
| 43 | Royalty PharmaRPRX · Health Care | PLN 78.9B | PLN 158.6B | PLN 275.80 | 0.12% down | 78% up | ||
| 44 | GrifolsGRFS · Health Care | PLN 87.9B | PLN 23.4B | PLN 34.41 | 0.81% down | 1% up | ||
| 45 | Vertex PharmaceuticalsVRTX · Health Care | PLN 103.1B | PLN 546.3B | PLN 2,154.58 | 0.32% up | 27% up | ||
| 46 | ViatrisVTRS · Health Care | PLN 149.5B | PLN 95B | PLN 82.90 | 0.83% up | 96% up | ||
| 47 | Regeneron PharmaceuticalsREGN · Health Care | PLN 163.1B | PLN 399.3B | PLN 3,859.97 | 0.24% up | 36% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | PLN 163.8B | PLN 199.6B | PLN 171.07 | 0.16% down | 74% up | ||
| 49 | Novo NordiskNVO · Health Care | PLN 323.9B | PLN 708.1B | PLN 160.66 | 1.82% down | 17% down | ||
| 50 | GSKGSK · Health Care | PLN 326.2B | PLN 394.9B | PLN 197.02 | 0.48% down | 6% up | ||
| 51 | Abbott LaboratoriesABT · Health Care | PLN 348.6B | PLN 727.6B | PLN 420.11 | 0.21% down | 17% down | ||
| 52 | Bristol-Myers SquibbBMY · Health Care | PLN 362B | PLN 493.9B | PLN 241.61 | 2.05% down | 34% up | ||
| 53 | Takeda PharmaceuticalTAK · Health Care | PLN 390.6B | PLN 275B | PLN 86.08 | 1.06% down | 54% up | ||
| 54 | NovartisNVS · Health Care | PLN 446.1B | PLN 1.19T | PLN 630.18 | 1.50% down | 25% up | ||
| 55 | Eli LillyLLY · Health Care | PLN 452.2B | PLN 5.01T | PLN 5,620.37 | 1.24% down | 35% up | ||
| 56 | AstraZenecaAZN · Health Care | PLN 458.6B | PLN 1.12T | PLN 722.49 | 1.41% down | 2% up | ||
| 57 | AbbVieABBV · Health Care | PLN 538.6B | PLN 2.05T | PLN 1,158.96 | 1.55% down | 26% up | ||
| 58 | Merck & CoMRK · Health Care | PLN 550.3B | PLN 1.39T | PLN 564.09 | 2.14% down | 51% up | ||
| 59 | SanofiSNY · Health Care | PLN 565.6B | PLN 457.8B | PLN 190.65 | 0.23% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | PLN 800.9B | PLN 2.67T | PLN 1,107.61 | 1.15% down | 38% up | ||
| 61 | PfizerPFE · Health Care | PLN 836.9B | PLN 646.9B | PLN 113.50 | 0.84% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0204 PLN).
Questions and answers
Which pharmaceuticals have the lowest total assets?
Veradermics (PLN 613.6M), Erasca (PLN 1.6B) and Definium Therapeutics (PLN 1.8B) have the lowest total assets of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 15:26 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total assets have a combined market value of PLN 20.52T as of 18 Nov 2026, 15:26 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.